CONCENTRATION-CONTROLLED IMMUNOSUPPRESSIVE REGIMENS USING CYCLOSPORINE WITH SIROLIMUS OR BREQUINAR IN HUMAN RENAL-TRANSPLANTATION

被引:0
作者
KAHAN, BD
机构
关键词
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页码:33 / 36
页数:4
相关论文
共 22 条
[1]  
CHEN SF, 1986, CANCER RES, V46, P5014
[2]   QUANTITATIVE-ANALYSIS OF DOSE-EFFECT RELATIONSHIPS - THE COMBINED EFFECTS OF MULTIPLE-DRUGS OR ENZYME-INHIBITORS [J].
CHOU, TC ;
TALALAY, P .
ADVANCES IN ENZYME REGULATION, 1984, 22 :27-55
[3]   PRECLINICAL EVALUATION OF A NEW POTENT IMMUNOSUPPRESSIVE AGENT, RAPAMYCIN [J].
KAHAN, BD ;
CHANG, JY ;
SEHGAL, SN .
TRANSPLANTATION, 1991, 52 (02) :185-191
[4]  
KAHAN BD, 1989, TRANSPLANT P, V21, P9
[6]   OPTIMIZATION OF CYCLOSPORINE THERAPY IN RENAL-TRANSPLANTATION BY A PHARMACOKINETIC STRATEGY [J].
KAHAN, BD ;
GREVEL, J .
TRANSPLANTATION, 1988, 46 (05) :631-644
[7]   THE SYNERGISTIC INTERACTIONS INVITRO AND INVIVO OF BREQUINAR SODIUM WITH CYCLOSPORINE OR RAPAMYCIN ALONE AND IN TRIPLE COMBINATION [J].
KAHAN, BD ;
TEJPAL, N ;
GIBBONSSTUBBERS, S ;
TU, YZ ;
WANG, M ;
STEPKOWSKI, S ;
CHOU, TC ;
TILNEY ;
MORRIS ;
STARZL .
TRANSPLANTATION, 1993, 55 (04) :894-900
[8]  
KAHAN BD, 1990, CLIN CHEM, V36, P1510
[9]   SYNERGISTIC INTERACTIONS OF CYCLOSPORINE AND RAPAMYCIN TO INHIBIT IMMUNE PERFORMANCES OF NORMAL HUMAN PERIPHERAL-BLOOD LYMPHOCYTES INVITRO [J].
KAHAN, BD ;
GIBBONS, S ;
TEJPAL, N ;
STEPKOWSKI, SM ;
CHOU, TC .
TRANSPLANTATION, 1991, 51 (01) :232-239
[10]   POSSIBLE CONTRIBUTION OF PRETRANSPLANT IMMUNE RESPONDER STATUS TO RENAL-ALLOGRAFT SURVIVAL DIFFERENCES OF BLACK VERSUS WHITE RECIPIENTS [J].
KERMAN, RH ;
KIMBALL, PM ;
VANBUREN, CT ;
LEWIS, RM ;
KAHAN, BD .
TRANSPLANTATION, 1991, 51 (02) :338-342